Sleep Medications and Melatonin: What you Should Know About Long Term Use

If you've been taking a sleep aid for months — or years — you're not alone. Prescription sleep medication use in the United States has roughly doubled over the past decade, and millions of Americans take melatonin nightly without a second thought. While this may be convenient, it’s important to consider the risks of long-term use of these medications, and know that a safer, more effective, drug-free alternative is available.

First, a Clarification That Changes Everything: Sedation Is Not Sleep

Benzodiazepines and z-drugs like zolpidem (Ambien) do not produce natural sleep. They produce sedation. These are neurologically different states.

Natural sleep cycles through distinct stages: light sleep, deep slow-wave sleep (SWS), and REM sleep. Each stage serves specific biological functions. Slow-wave sleep is where growth hormone is released, physical tissue is repaired, and glucose metabolism is regulated. REM sleep is where emotional processing, memory consolidation, and cognitive restoration happen. Healthy, restorative sleep requires adequate time in both.

Research published in the Journal of Neuroscience found that the NREM sleep produced by zolpidem has measurably reduced power across most EEG frequencies compared to natural drug-free sleep. A more recent Concordia University study found that long-term users of benzodiazepines had significantly lower amounts of deep sleep compared to people with insomnia who weren't taking medication at all. Patients taking these medications had worse deep sleep architecture than untreated insomniacs.

The patients who describe waking up exhausted after eight hours on Ambien are not imagining things. Their bodies spent the night sedated, but they did not have restorative sleep.

The Risks of Long-Term Sleep Medication Use

Prescribing guidelines for both benzodiazepines (Restoril, Halcion) and z-drugs (Ambien, Lunesta, Sonata) recommend use of no longer than two to four weeks. Despite this, around 20% of people prescribed sleep aids use them for more than six months, and many have been on them for years. What happens to the body during that time is worth understanding.

Cognitive impairment. Long-term benzodiazepine use has been associated with impaired cognitive function across multiple domains, including memory, attention, and processing speed.

Falls and accidents. Benzodiazepines alter reaction time and psychomotor function in ways that meaningfully increase fall risk, particularly in older adults. Additionally, they are the second most commonly involved substance in traffic accidents after alcohol.

Dependence and rebound insomnia. Physical dependence on sleep medications develops quickly, often within days of consistent use. When patients try to stop, they experience rebound insomnia: a worsening of sleep that is often more severe than their original insomnia. This is a withdrawal effect, not evidence that the medication was working or that the underlying insomnia is incurable. But it's frequently interpreted as the latter, trapping patients in long-term use they never intended.

The quality-of-life toll. A 2025 microsimulation study published in a peer-reviewed journal, funded by the National Heart, Lung and Blood Institute, found that prescription sleep medications in the long term actually worsen quantity and quality of life for middle-aged and older adults, and concluded that deprescribing efforts would likely improve outcomes.

What About Melatonin? It's More Complicated Than You Think.

Melatonin occupies a different category. It's not a sedative — it's a hormone your body naturally produces to signal that darkness has arrived and sleep should begin. Supplemental melatonin does not cause dependence or withdrawal, and at appropriate doses (0.5 to 3mg), safety research is generally reassuring for short-term use.

But there are two things most people taking nightly melatonin for insomnia don't know.

It probably isn't doing what you think it's doing.

Melatonin is genuinely effective for circadian rhythm disorders — jet lag, shift work, delayed sleep phase syndrome. However, for chronic insomnia, difficulty falling or staying asleep due to hyperarousal, anxiety, conditioned wakefulness, the evidence is far weaker. A systematic review and meta-analysis published in the Journal of Sleep Research found that melatonin was not significantly effective in improving sleep onset latency, total sleep time, or sleep efficiency. The effect in adults with primary insomnia is, in the words of the AHRQ evidence review, "clinically insignificant."

Emerging safety concerns deserve attention.

A 2025 preliminary study presented at the American Heart Association's Scientific Sessions, drawing on five years of health records from over 130,000 adults with insomnia, found that long-term melatonin use (one year or more) was associated with a significantly higher risk of heart failure diagnosis, heart failure hospitalization, and all-cause mortality compared to non-users. This research is preliminary and has not yet been peer-reviewed, and the study had important methodological limitations. But it signals that the assumption that melatonin is entirely harmless for indefinite use may not be well-founded — particularly given that melatonin is sold as an unregulated dietary supplement in the United States, with no FDA oversight of dosing, purity, or manufacturing.

The honest summary on melatonin: it may be a reasonable short-term support tool for circadian disruption such as adjusting to a different time zone, but nightly use for chronic insomnia is likely providing minimal benefit for the actual problem while bypassing the intervention that would actually solve it.

What Actually Helps

Cognitive Behavioral Therapy for Insomnia (CBT-I) doesn't sedate you, override your biology, or mask the problem. It works by identifying and correcting the behavioral and cognitive patterns that are perpetuating your insomnia such as the conditioned wakefulness, the anxiety around sleep, the compensatory habits that make things worse over time.

The outcomes data is compelling and consistent throughout decades of research. Multiple head-to-head trials show CBT-I produces equivalent outcomes to sleep medication in the short term, with significantly better results at six and twelve-month follow-up, because CBT-I maintains its gains after treatment ends while medication effects largely disappear after discontinuation.

CBT-I also improves sleep architecture in ways that medication does not. CBT-I restores the natural cycling between sleep stages that insomnia and sleep medications disrupt. Patients don't just sleep longer, they get the deep, restorative sleep their bodies need. And unlike medication, there is no withdrawal, no rebound insomnia, no dependence, no side effects, and no ongoing costs. The gains belong to the patient permanently.

The Question Worth Asking

If you've been taking a sleep aid for months or years, the question to consider is whether the medication is solving your insomnia or simply deferring it, night after night, while real treatment remains out of reach.

CBT-I is the treatment sleep specialists , the American College of Physicians, the National Institutes of Health, and the American Academy of Sleep Medicine recommend before medication because it actually works. It addresses the mechanisms driving your insomnia rather than sedating you past them. And for patients who've been on medication for years, it is also the evidence-based path to safely tapering off, with prescriber coordination.